| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 Hospital General de Requena, Unidad de Neumología, Servicio de Medicina Interna, Requena (Valencia), Spain
2 Hospital General de Requena, Servicio de Medicina Interna, Requena (Valencia), Spain
3 Hospital General de Requena, Servicio de Urgencias, Requena (Valencia), Spain
Correspondence to:
Correspondence to:
Dr J J Soler-Cataluña
Unidad de Neumología, Servicio de Medicina Interna, Hospital General de Requena, Paraje Casablanca s/n 46340, Requena (Valencia), Spain; jjsoler{at}telefonica.net
Background: Patients with chronic obstructive pulmonary disease (COPD) often present with severe acute exacerbations requiring hospital treatment. However, little is known about the prognostic consequences of these exacerbations. A study was undertaken to investigate whether severe acute exacerbations of COPD exert a direct effect on mortality.
Methods: Multivariate techniques were used to analyse the prognostic influence of acute exacerbations of COPD treated in hospital (visits to the emergency service and admissions), patient age, smoking, body mass index, co-morbidity, long term oxygen therapy, forced spirometric parameters, and arterial blood gas tensions in a prospective cohort of 304 men with COPD followed up for 5 years. The mean (SD) age of the patients was 71 (9) years and forced expiratory volume in 1 second was 46 (17)%.
Results: Only older age (hazard ratio (HR) 5.28, 95% CI 1.75 to 15.93), arterial carbon dioxide tension (HR 1.07, 95% CI 1.02 to 1.12), and acute exacerbations of COPD were found to be independent indicators of a poor prognosis. The patients with the greatest mortality risk were those with three or more acute COPD exacerbations (HR 4.13, 95% CI 1.80 to 9.41).
Conclusions: This study shows for the first time that severe acute exacerbations of COPD have an independent negative impact on patient prognosis. Mortality increases with the frequency of severe exacerbations, particularly if these require admission to hospital.
Abbreviations: BMI, body mass index; COPD, chronic obstructive pulmonary disease; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; LTOT, long term oxygen therapy; PaO2, PaCO2, arterial oxygen and carbon dioxide tensions
Keywords: chronic obstructive pulmonary disease; exacerbations; hospitalisation; mortality; prognostic value
Relevant Article
Thorax 2005 60: 885.
This article has been cited by other articles:
|
|
 |
|
  T. A. R. Seemungal, T. M. A. Wilkinson, J. R. Hurst, W. R. Perera, R. J. Sapsford, and J. A. Wedzicha Long-term Erythromycin Therapy Is Associated with Decreased Chronic Obstructive Pulmonary Disease Exacerbations Am. J. Respir. Crit. Care Med., December 1, 2008; 178(11): 1139 - 1147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A Wedzicha Antibiotics at COPD exacerbations: the debate continues Thorax, November 1, 2008; 63(11): 940 - 942. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Roche, M. Zureik, D. Soussan, F. Neukirch, D. Perrotin, and the Urgence BPCO (COPD Emergency) Scientific Commi Predictors of outcomes in COPD exacerbation cases presenting to the emergency department Eur. Respir. J., October 1, 2008; 32(4): 953 - 961. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Foreman, D. L. DeMeo, C. P. Hersh, V. J. Carey, V. S. Fan, J. J. Reilly, S. D. Shapiro, and E. K. Silverman Polymorphic variation in surfactant protein B is associated with COPD exacerbations Eur. Respir. J., October 1, 2008; 32(4): 938 - 944. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Seemungal, A. Sykes, and and the ICEAD Contributors Recent advances in exacerbations of COPD Thorax, October 1, 2008; 63(10): 850 - 852. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Stolz, M. Christ-Crain, N. G. Morgenthaler, D. Miedinger, J. Leuppi, C. Muller, R. Bingisser, J. Struck, B. Muller, and M. Tamm Plasma Pro-Adrenomedullin But Not Plasma Pro-Endothelin Predicts Survival in Exacerbations of COPD Chest, August 1, 2008; 134(2): 263 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. N. Keene, P. M. A. Calverley, P. W. Jones, J. Vestbo, and J. A. Anderson Statistical analysis of exacerbation rates in COPD: TRISTAN and ISOLDE revisited Eur. Respir. J., July 1, 2008; 32(1): 17 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Clini and N. Ambrosino Nonpharmacological treatment and relief of symptoms in COPD Eur. Respir. J., July 1, 2008; 32(1): 218 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Quint, R. Baghai-Ravary, G. C. Donaldson, and J. A. Wedzicha Relationship between depression and exacerbations in COPD Eur. Respir. J., July 1, 2008; 32(1): 53 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kaplan, P. Hernandez, and D. O'Donnell Less smoke, more fire: What's new for you in the latest COPD guidelines? Can Fam Physician, May 1, 2008; 54(5): 737 - 739. [Full Text] [PDF]
|
|
|
|
|
|
P. Albert and P. M. A. Calverley Drugs (including oxygen) in severe COPD Eur. Respir. J., May 1, 2008; 31(5): 1114 - 1124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Stolz, T. Breidthardt, M. Christ-Crain, R. Bingisser, D. Miedinger, J. Leuppi, B. Mueller, M. Tamm, and C. Mueller Use of B-Type Natriuretic Peptide in the Risk Stratification of Acute Exacerbations of COPD Chest, May 1, 2008; 133(5): 1088 - 1094. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Gonzalez, E. Servera, and J. Marin Importance of Noninvasively Measured Respiratory Muscle Overload Among the Causes of Hospital Readmission of COPD Patients Chest, April 1, 2008; 133(4): 941 - 947. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Welte Acute Exacerbation of Chronic Obstructive Pulmonary Disease: More a Functional than an Inflammatory Problem? Am. J. Respir. Crit. Care Med., January 15, 2008; 177(2): 130 - 131. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Briggs, M. Spencer, H. Wang, D. Mannino, and D. D. Sin Development and Validation of a Prognostic Index for Health Outcomes in Chronic Obstructive Pulmonary Disease Arch Intern Med, January 14, 2008; 168(1): 71 - 79. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Wedzicha, P. M. A. Calverley, T. A. Seemungal, G. Hagan, Z. Ansari, R. A. Stockley, and for the INSPIRE Investigators The Prevention of Chronic Obstructive Pulmonary Disease Exacerbations by Salmeterol/Fluticasone Propionate or Tiotropium Bromide Am. J. Respir. Crit. Care Med., January 1, 2008; 177(1): 19 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. K. Silverman Exacerbations in Chronic Obstructive Pulmonary Disease: Do They Contribute to Disease Progression? Proceedings of the ATS, December 1, 2007; 4(8): 586 - 590. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Wedzicha and J. R. Hurst Structural and Functional Co-conspirators in Chronic Obstructive Pulmonary Disease Exacerbations Proceedings of the ATS, December 1, 2007; 4(8): 602 - 605. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Abusriwil and R. A. Stockley The Interaction of Host and Pathogen Factors in Chronic Obstructive Pulmonary Disease Exacerbations and Their Role in Tissue Damage Proceedings of the ATS, December 1, 2007; 4(8): 611 - 617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Anzueto, S. Sethi, and F. J. Martinez Exacerbations of Chronic Obstructive Pulmonary Disease Proceedings of the ATS, October 1, 2007; 4(7): 554 - 564. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Powrie, T. M. A. Wilkinson, G. C. Donaldson, P. Jones, K. Scrine, K. Viel, S. Kesten, and J. A. Wedzicha Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD Eur. Respir. J., September 1, 2007; 30(3): 472 - 478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sethi, R. Sethi, K. Eschberger, P. Lobbins, X. Cai, B. J. B. Grant, and T. F. Murphy Airway Bacterial Concentrations and Exacerbations of Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., August 15, 2007; 176(4): 356 - 361. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Beaulieu-Genest, D. Chretien, F. Maltais, K. Pelletier, J.-G. Parent, and Y. Lacasse Self-administered prescriptions of oral steroids and antibiotics in chronic obstructive pulmonary disease: are we doing more harm than good? Chronic Respiratory Disease, August 1, 2007; 4(3): 143 - 147. [Abstract] [PDF]
|
|
|
|
|
|
B. R. Celli and P. J. Barnes Exacerbations of chronic obstructive pulmonary disease Eur. Respir. J., June 1, 2007; 29(6): 1224 - 1238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C-G. Lofdahl, D. S. Postma, N. B. Pride, J. Boe, and A. Thoren Possible protection by inhaled budesonide against ischaemic cardiac events in mild COPD Eur. Respir. J., June 1, 2007; 29(6): 1115 - 1119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Stolz, M. Christ-Crain, N. G. Morgenthaler, J. Leuppi, D. Miedinger, R. Bingisser, C. Muller, J. Struck, B. Muller, and M. Tamm Copeptin, C-Reactive Protein, and Procalcitonin as Prognostic Biomarkers in Acute Exacerbation of COPD Chest, April 1, 2007; 131(4): 1058 - 1067. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. G. Cote, L. J. Dordelly, and B. R. Celli Impact of COPD Exacerbations on Patient-Centered Outcomes Chest, March 1, 2007; 131(3): 696 - 704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. R. Perera, J. R. Hurst, T. M. A. Wilkinson, R. J. Sapsford, H. Mullerova, G. C. Donaldson, and J. A. Wedzicha Inflammatory changes, recovery and recurrence at COPD exacerbation Eur. Respir. J., March 1, 2007; 29(3): 527 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J R Hurst and J A Wedzicha What is (and what is not) a COPD exacerbation: thoughts from the new GOLD guidelines Thorax, March 1, 2007; 62(3): 198 - 199. [Full Text] [PDF]
|
|
|
|
|
|
V. Soyseth, P. H. Brekke, P. Smith, and T. Omland Statin use is associated with reduced mortality in COPD Eur. Respir. J., February 1, 2007; 29(2): 279 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Kardos, M. Wencker, T. Glaab, and C. Vogelmeier Impact of Salmeterol/Fluticasone Propionate versus Salmeterol on Exacerbations in Severe Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., January 15, 2007; 175(2): 144 - 149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Rodriguez-Roisin Impacting patient-centred outcomes in COPD: exacerbations and hospitalisations Eur. Respir. Rev., December 1, 2006; 15(99): 47 - 51. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. A. Calverley Exercise and dyspnoea in COPD Eur. Respir. Rev., December 1, 2006; 15(100): 72 - 79. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Hurst, G. C. Donaldson, W. R. Perera, T. M. A. Wilkinson, J. A. Bilello, G. W. Hagan, R. S. Vessey, and J. A. Wedzicha Use of Plasma Biomarkers at Exacerbation of Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., October 15, 2006; 174(8): 867 - 874. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P M A Calverley Caring for the burden of COPD. Thorax, October 1, 2006; 61(10): 831 - 832. [Full Text] [PDF]
|
|
|
|
|
|
R Rodriguez-Roisin COPD exacerbations {middle dot} 5: Management. Thorax, June 1, 2006; 61(6): 535 - 544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A M Yohannes, M J Connolly, J J Soler-Cataluna, M A Martinez-Garcia, and P Roman Sanchez Effect of dichotomising age in multivariate model analysis. Thorax, June 1, 2006; 61(6): 548 - 549. [Full Text] [PDF]
|
|
|
|
|
|
L. M. Fabbri, F. Luppi, B. Beghe, and K. F. Rabe Update in chronic obstructive pulmonary disease 2005. Am. J. Respir. Crit. Care Med., May 15, 2006; 173(10): 1056 - 1065. [Full Text] [PDF]
|
|
|
|
|
|
J. A. Wedzicha and T. Wilkinson Impact of Chronic Obstructive Pulmonary Disease Exacerbations on Patients and Payers Proceedings of the ATS, May 1, 2006; 3(3): 218 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G C Donaldson and J A Wedzicha COPD exacerbations {middle dot} 1: Epidemiology Thorax, February 1, 2006; 61(2): 164 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J A Wedzicha and T A R Seemungal Inhaled corticosteroids in COPD: a light at the end of the tunnel? Thorax, December 1, 2005; 60(12): 977 - 978. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
